US › Healthcare

Valion Bio Inc (VBIO)

US · Healthcare · Biotechnology

$2.23+7.21%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$1.1M

Revenue YoY

+1190.3%

Net profit

$-7.1M

EPS

$-2.17

Net margin

-640.1%

Key statistics

Market cap

$2.0M

Forward P/E

0.0

P/B

0.47

Book value

$1.02

EPS (TTM)

$-184.45

52-week high

$80.20

52-week low

$2.16

50-day MA

$6.77

200-day MA

$22.46

Beta

1.79

Shareholding

Insiders

0.62%

Institutions

12.42%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	2.80%
Sanctuary Advisors, LLC	1.95%
Marex Group Ltd	1.89%
HRT FINANCIAL LLC	1.35%
XTX Topco Ltd	0.33%
UBS Group AG	0.08%
Tower Research Capital LLC	0.02%
SBI Securities Co Ltd	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Valion Bio Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.